We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Indiana will move to import prescription drugs from Canada if the federal government doesn't act by next March to lower drug prices, according to the state's top elected official.
Aggressive substitution of generics in place of their brand counterparts can be a major source of savings for state Medicaid programs, according to a recent report issued by the Centers for Medicare & Medicaid Services (CMS).
Biopharmaceutical firm Cell Therapeutics has acknowledged that it is likely it promoted its cancer drug Trisenox for off-label uses, an action that would violate federal laws.
A report by the U.S. Office of Government Ethics (OGE) concluded that reforms proposed by the National Institutes of Health (NIH) intended to head off employee conflicts of interest in performing outside consulting work do not go far enough to remedy the problem.